Imperial to take the lead in creating new London centre for genetic research
-London Development Agency
For immediate release
Wednesday 19 April 2006
Imperial College London is to take the lead in the creation of a new London based centre for clinical genetic research with a consortium of leading scientific research institutions.
The London Genetics Centre will provide access to knowledge and expertise in clinical genetics across London's biomedical institutions, and help position London as the leading European centre for genetic medicine.
The research in the centre will focus on the genetics underlying five key clinical areas, including cardiovascular disease, mental health, respiratory disease, endocrine and autoimmune disease and oncology.
The centre aims to improve interaction between academia, NHS and industry, by improving access to clinical trials for patients, developing the infrastructure needed for clinical trials, improving the analysis of routinely collected data, and setting up fully integrated clinical trials from 'bench to bedside'.
Professor Stephen Smith
, Principal of the Faculty of Medicine
at Imperial College London, said: "There is currently a huge amount
of genetics expertise in the many world class biomedical research
institutions across London, and this new centre will help bring it
all together. It will ultimately improve collaboration between
biomedical research institutions, and we also hope to improve links
between the NHS and pharmaceutical industry for the benefit of
patients."
The new centre will offer a range of services including the collection and analysis of biological samples and data from patients in clinical trials, developing the use of genetic and genomic technologies and data into clinical trials, and gaining sponsorship for clinical genetics projects from pharmaceutical companies.
The London Development Agency has contributed GBP2 million for establishment of the London Genetics Centre whose members will include Imperial College London, University College London, Kings College London, St Georges, University of London, Queen Mary University of London, the Institute of Cancer Research and the London School of Hygiene and Tropical Medicine.
The centre is currently recruiting a Chief Executive to lead and manage its interactions with industry, academia and the NHS.
For further information please contact:
Tony Stephenson
Press Officer
Communications Division
Tel: +44 (0)20 7594 6712
Mobile: +44 (0)7753 739766
E-mail: at.stephenson@imperial.ac.uk
Notes to editors:
1. Imperial Business Development Group is the primary interface
of Imperial College London with industry. The group is dedicated to
developing and supporting long-term, value generating research
partnerships between industry and university investigators through
an understanding of business needs, coupled with access to leading
edge science. Imperial has one of the highest levels of industry
funding for any UK university at £30m in 2005 and continues
to be independently rated as one of the top UK and global
universities for the quality of its teaching and research.
Website: www.imperial.ac.uk/businessdevelopment
2. Consistently rated in the top three UK university
institutions, Imperial College London is a world leading
science-based university whose reputation for excellence in
teaching and research attracts students (11,000) and staff (6,000)
of the highest international quality.
Innovative research at the College explores the interface between
science, medicine, engineering and management and delivers
practical solutions that enhance the quality of life and the
environment - underpinned by a dynamic enterprise culture.
Website: www.imperial.ac.uk
Jump to: News Release Archive







